TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
51,432
$63.75
$3,278,739
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
50,000
$8.6
$430,200
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Non-Qualified Stock Option (right to buy)
50,000
$8.6
$430,200
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Non-Qualified Stock Option (right to buy)
53,896
$7.3
$393,279
Option
YOUNG KEVINofficer: Chief Operating Officerofficer: Chief Operating Officer
Non-Qualified Stock Option (right to buy)
24,000
$32.02
$768,480
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
53,896
$62.58
$3,372,812
Sale
YOUNG KEVINofficer: Chief Operating Officerofficer: Chief Operating Officer
Common Stock
24,000
$62.03
$1,488,720
Sale
DENNY JAMES Mdirectordirector
Common Stock
30,000
$62.03
$1,860,870
Option
DENNY JAMES Mdirectordirector
Non-Qualified Stock Option (right to buy)
40,000
$4.96
$198,280
Option
DENNY JAMES Mdirectordirector
Common Stock
40,000
$4.96
$198,280
Option
YOUNG KEVINofficer: Chief Operating Officerofficer: Chief Operating Officer
Common Stock
24,000
$32.02
$768,480
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
53,896
$7.3
$393,279
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
30,000
$7.3
$218,910
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
30,000
$61.91
$1,857,300
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Non-Qualified Stock Option (right to buy)
30,000
$7.3
$218,910
Showing 2650 to 2700 of 3053 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.